My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1801

    1.

    Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

    Pospisilik JA, Martin J, Doty T, Ehses JA, Pamir N, Lynn FC, Piteau S, Demuth HU, McIntosh CH, Pederson RA.

    Diabetes. 2003 Mar;52(3):741-50.PMID: 12606516 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats.

    Pospisilik JA, Stafford SG, Demuth HU, Brownsey R, Parkhouse W, Finegood DT, McIntosh CH, Pederson RA.

    Diabetes. 2002 Apr;51(4):943-50.PMID: 11916911 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    beta-cell failure in diabetes and preservation by clinical treatment.

    Wajchenberg BL.

    Endocr Rev. 2007 Apr;28(2):187-218. Epub 2007 Mar 12. Review.PMID: 17353295 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.

    Sudre B, Broqua P, White RB, Ashworth D, Evans DM, Haigh R, Junien JL, Aubert ML.

    Diabetes. 2002 May;51(5):1461-9.PMID: 11978643 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [New therapeutic approach in patients with type 2 diabetes based on glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP)]

    Kluz J, Adamiec R.

    Postepy Hig Med Dosw (Online). 2006;60:15-23. Review. Polish. PMID: 16407790 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice.

    Reimer MK, Holst JJ, Ahrén B.

    Eur J Endocrinol. 2002 May;146(5):717-27.PMID: 11980629 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.

    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.

    J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13.PMID: 12788877 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs.

    Deacon CF, Wamberg S, Bie P, Hughes TE, Holst JJ.

    J Endocrinol. 2002 Feb;172(2):355-62.PMID: 11834453 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.

    Kim SJ, Nian C, Doudet DJ, McIntosh CH.

    Diabetes. 2008 May;57(5):1331-9. Epub 2008 Feb 25.PMID: 18299314 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus.

    McIntosh CH, Demuth HU, Kim SJ, Pospisilik JA, Pederson RA.

    Int J Biochem Cell Biol. 2006;38(5-6):860-72. Epub 2006 Jan 11. Review.PMID: 16442340 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.

    Tourrel C, Bailbé D, Meile MJ, Kergoat M, Portha B.

    Diabetes. 2001 Jul;50(7):1562-70.PMID: 11423477 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.

    Liu X, Harada N, Yamane S, Kitajima L, Uchida S, Hamasaki A, Mukai E, Toyoda K, Yamada C, Yamada Y, Seino Y, Inagaki N.

    Life Sci. 2009 Jun 19;84(25-26):876-81. Epub 2009 Apr 7.PMID: 19358859 [PubMed - indexed for MEDLINE]Related articles

    13.

    Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes.

    Gautier JF, Fetita S, Sobngwi E, Salaün-Martin C.

    Diabetes Metab. 2005 Jun;31(3 Pt 1):233-42. Review.PMID: 16142014 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.

    Parker JC, Lavery KS, Irwin N, Green BD, Greer B, Harriott P, O'Harte FP, Gault VA, Flatt PR.

    J Endocrinol. 2006 Oct;191(1):93-100.PMID: 17065392 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.

    Dachicourt N, Serradas P, Bailbé D, Kergoat M, Doaré L, Portha B.

    J Endocrinol. 1997 Nov;155(2):369-76.PMID: 9415071 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Inhibition of dipeptidyl peptidase-4 augments insulin secretion in response to exogenously administered glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, pituitary adenylate cyclase-activating polypeptide, and gastrin-releasing peptide in mice.

    Ahrén B, Hughes TE.

    Endocrinology. 2005 Apr;146(4):2055-9. Epub 2004 Dec 16.PMID: 15604213 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Long-term treatment with dipeptidyl peptidase IV inhibitor improves hepatic and peripheral insulin sensitivity in the VDF Zucker rat: a euglycemic-hyperinsulinemic clamp study.

    Pospisilik JA, Stafford SG, Demuth HU, McIntosh CH, Pederson RA.

    Diabetes. 2002 Sep;51(9):2677-83.PMID: 12196458 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The entero-insular axis: implications for human metabolism.

    Ranganath LR.

    Clin Chem Lab Med. 2008;46(1):43-56. Review.PMID: 18020966 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.

    Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM.

    J Endocrinol. 2005 Jun;185(3):457-65.PMID: 15930172 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The enteroinsular axis in dipeptidyl peptidase IV-negative rats.

    Pederson RA, Kieffer TJ, Pauly R, Kofod H, Kwong J, McIntosh CH.

    Metabolism. 1996 Nov;45(11):1335-41.PMID: 8931636 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity